Cited by 883Neuropeptides and Animal PhysiologyNeuroendocrine regulation and behaviorChemical Synthesis and Analysis

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Open access

Goldstein, A, Tachibana, S, Lowney, L I, Hunkapiller, M, Hood, L·1979·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.76.12.6666PMC PMC411929

Open this paper in CoChat — free account

Abstract

We describe the opioid properties of a tridecapeptide, the sequence of which corresponds to the NH2-terminal sequence of dynorphin, a novel porcine pituitary endorphin. It contains [Leu]enkephalin. In the guinea pig ileum longitudinal muscle preparation it is about 700 times more potent than [Leu]enkephalin. Its effects in this tissue are blocked completely by naloxone, but the apparent affinity of naloxone is 1/13th that for blockade of [Leu]enkephalin or normorphine. In the mouse vas deferens, this peptide is 3 times more potent than [Leu]enkephalin. Well-washed rat brain membranes degrade the peptide rapidly, suggesting the presence of a membrane-bound degradative enzyme. The peptide displays considerable immunoreactivity in assays with antisera that have been used for the immunohistochemical localization of [Leu]enkephalin. The remarkable enhancement of the potency of [Leu]enkephalin by the COOH-terminal extension -Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-OH suggests new interpretations concerning the structure of opiate receptors and the function of the enkephalin pentapeptides.

Integrity signals

Registry

Crossref · 10.1073/pnas.76.12.6666

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
Hunter, W. M., & Greenwood, F. C. (1962) · Nature · doi:10.1038/194495a0 · Cited by 6,902
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Purification and properties
Cox, B. M., Opheim, K. E., Teschemacher, H., & D, A. G. M. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90272-6 · Cited by 1,708
Immunohistochemical localization of enkephalin in rat brain and spinal cord
Sar, M., Stumpf, W. E., Miller, R. J., Chang, K., & Cuatrecasas, P. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901820103 · Cited by 822
Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.
Chang, K. J., & Cuatrecasas, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30115-1 · Cited by 683
[D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide Analgesic
Pert, C. B., Pert, A., Chang, J., & Fong, B. T. W. (1976) · Science · doi:10.1126/science.968485 · Cited by 469
Endogenous and Exogenous Opiate Agonists and Antagonists
(1980) · Elsevier eBooks · doi:10.1016/c2013-0-03337-3 · Cited by 447
EFFECT OF MORPHINE ON ADRENERGIC TRANSMISSION IN THE MOUSE VAS DEFERENS. ASSESSMENT OF AGONIST AND ANTAGONIST POTENCIES OF NARCOTIC ANALGESICS
Hughes, J. W., Kosterlitz, H. W., & Leslie, F. M. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07373.x · Cited by 405
Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (Polybrene), and high pressure liquid chromatography
Hunkapiller, M. W., & Hood, L. (1978) · Biochemistry · doi:10.1021/bi00604a016 · Cited by 383
Self-citation
In Vitro Models in the Study of Structure-Activity Relationships of Narcotic Analgesics
Kosterlitz, H. W., & Waterfield, A. A. (1975) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.15.040175.000333 · Cited by 293

Show all 18 references

Sorted by citations

Items 401–500 of 883

Effects of naltrexone on lipopolysaccharide-induced sepsis in rats
Lin, S., Lee, Y., Chang, H., Cheng, Y., & Yen, M. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-0647-x · Cited by 22
Structure and orientation of dynorphin bound to lipid bilayers by 13C solid-state NMR
Uezono, T., Toraya, S., Obata, M., Nishimura, K., Tuzi, S., Saitô, H., & Naito, A. (2005) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2005.02.037 · Cited by 22
Effect of amino acid substitution in amphiphilic α-helical peptides on peptide-phospholipid membrane interaction
Niidome, T., Anzai, S., Sonoda, J., Tokunaga, Y., Nakahara, M., Hatakeyama, T., & Aoyagi, H. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199907)5:7 · Cited by 12
Synthesis and Pharmacological Evaluation of [3H]HS665, a Novel, Highly Selective Radioligand for the Kappa Opioid Receptor
Guerrieri, E., Mallareddy, J. R., Tóth, G., Schmidhammer, H., & Spetea, M. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5002792 · Cited by 22
Antinociceptive effects of dynorphin peptides in a model of inflammatory pain
Beyer, A., Schäfer, M., & Stein, C. (1997) · Pain · doi:10.1016/s0304-3959(97)03327-7 · Cited by 22
“The dynorphin A (DYN) peptides DYN-(1-13) and DYN(1-17) were originally described and named for their extraordinary potency in suppressing muscle twitch of the guinea pig ileum muscle preparation, a bioassay for opioid activity (Goldstein et al., 1979; Goldstein et al., 1981).”
Background
Recent Advances in the Search for the μ-Opioidergic System: Differential Mechanism of G-Protein Activation Induced by Endogenous μ-Opioid Peptides, Endomorphin and β-Endorphin
Mizoguchi, H., Tseng, L. F., Suzuki, T., Sora, I., & Narita, M. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.89.229 · Cited by 22
Solution structure of human β-endorphin in helicogenic solvents: an NMR study
Saviano, G., Crescenzi, O., Picone, D., Temussi, P., & Tancredi, T. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199909)5:9 · Cited by 22
WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist
Wood, P. L., Pilapil, C., Thakur, M., & Richard, J. W. (1984) · Pharmaceutical Research · doi:10.1023/a:1016386811268 · Cited by 22
Distribution of Opioids in Brain and Peripheral Tissues
Schäfer, M. K.-H., Day, R. W., Watson, S. J., & Akil, H. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_3 · Cited by 22
Characterization of the 80,000 molecular weight form of neurophysin isolated from bovine neurohypophysis.
Béguin, P., Nicolas, P., Boussetta, H., Fahy, C., & Cohen, P. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52544-3 · Cited by 22
Chemical characteristics of endorphins in human cerebrospinal fluid
Wahlström, A., & Terenius, L. Y. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80228-6 · Cited by 22
Neuroblastoma × Glioma Hybrid Cells Synthesize Enkephalin‐Like Opioid Peptides
Gläser, T., Hübner, K., & Hamprecht, B. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb04701.x · Cited by 22
“During the past 5 years, several opioid peptides from different sources have been isolated and characterized (Hughes et al., 1975; Bradbury et al., 1976; Cox et al., 1976; Guillemin et al., 1976; Li and Chung, 1976; Seidah et al., 1976; Goldstein et al., 1979; Huang et al., 1979; Kangawa et al., 1979, 1981; Erspamer a…”
Background
Dynorphin A(1–13) modulates apomorphine-induced behaviors using multidimensional behavioral analyses in the mouse
Ukai, M., Toyoshi, T., & Kameyama, T. (1989) · Brain Research · doi:10.1016/0006-8993(89)90778-6 · Cited by 22
Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimates
Ho, W. K. K., Cox, B. M., Chavkin, C., & D, A. G. M. (1980) · Neuropeptides · doi:10.1016/0143-4179(80)90017-7 · Cited by 22
The antagonistic effects of naloxone on hypermotility in mice induced by dynorphin-(1-13) using a multi-dimensional behavioral analysis
UKAI, M. (1984) · Neuropharmacology · doi:10.1016/s0028-3908(84)80009-x · Cited by 22
Behavioral, Neural, and Molecular Mechanisms of Conditioned Mate Preference: The Role of Opioids and First Experiences of Sexual Reward
Quintana, G. R., Cionnaith, C. E. M., & Pfaus, J. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168928 · Cited by 23
Involvement of kappa/dynorphin system in the development of tolerance to nicotine‐induced antinociception
Galeote, L., Maldonado, R. J., & Berrendero, F. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05247.x · Cited by 21
“Although dynorphin was identified as an endogenous KOP-r agonist with lower affinity for DOP-r and MOP-r (Goldstein et al. 1979), provided of antinociceptive effects (Ossipov et al. 1996), this peptide has significant non-opioid activity (Vanderah et al. 2001).”
In Silico Identification of Tripeptides as Lead Compounds for the Design of KOR Ligands
Stefanucci, A., Iobbi, V., Valle, A. D., Scioli, G. A., Pieretti, S., Minosi, P., Mirzaie, S., Novellino, E., & Mollica, A. (2021) · Molecules · doi:10.3390/molecules26164767 · Cited by 21
“The human KOR (PDB code 4DJH) was retrieved from PDB in complex with a selective antagonist JDTic ((3R)-7-hydroxy-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl) -3,4-dimethylpiperidin1-yl]-3-methylbutan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide) [6].”
BackgroundMethod
Preparation of specifically tritiated endomorphins
Tömböly, C., Dixit, R., Lengyel, I., Borsodi, A. D., & Tóth, G. (2001) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.463 · Cited by 21
From Synapse to Function: A Perspective on the Role of Neuroproteomics in Elucidating Mechanisms of Drug Addiction
Natividad, L. A., Buczynski, M. W., McClatchy, D. B., & Yates, J. R. (2018) · Proteomes · doi:10.3390/proteomes6040050 · Cited by 21
Cloning and Characterization of Xen-dorphin Prohormone from Xenopus laevis
Pattee, P., Ilie, A., Benyhe, S., Tóth, G., Borsodi, A. D., & Nagalla, S. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306724200 · Cited by 21
The role of endogenous peptides in the action of opioid analgesics.
Adams, M. L., Brase, D., Welch, S. P., & Dewey, W. L. (1986) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(86)80124-x · Cited by 23
Recent Advances in the Search for the μ-Opioidergic System: Endomorphin-Induced Motivational Effect: Differential Mechanism of Endomorphin-1 and Endomorphin-2
Narita, M., Ozaki, S., & Suzuki, T. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.89.224 · Cited by 21
P art X. P otential R ole of E ndogenous O pioids in S chizophrenia and A ffective D isorders : DEPRESSIVE PHENOMENOLOGY AND LEVELS OF CEREBROSPINAL FLUID ENDORPHINS*
Ågren, H., Terenius, L. Y., & Wahlström, A. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39510.x · Cited by 21
Regulation of opioid gene expression
Civelli, O., Birnberg, N. C., Comb, M. J., DOUGLASS, J. O., Lissitzky, J., Uhler, M. D., & Herbert, E. (1983) · Peptides · doi:10.1016/0196-9781(83)90013-x · Cited by 21
Electrophysiological evidence for º-agonist activity of dynorphin in rat brain
BROOKES, A. (1984) · Neuropharmacology · doi:10.1016/s0028-3908(84)80016-7 · Cited by 21
Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation
Li, X., Marchant, N. J., & Shaham, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403603111 · Cited by 20
Opioid Peptides and Their Receptors in Chickens: Structure, Functionality, and Tissue Distribution
Bu, G., Cui, L., Lv, C., Lin, D., Huang, L., Li, Z., Li, J., Zeng, X., & Wang, Y. (2020) · Peptides · doi:10.1016/j.peptides.2020.170307 · Cited by 20
Peripheral administration of κ-opioid receptor antagonist stimulates gonadotropin-releasing hormone pulse generator activity in ovariectomized, estrogen-treated female goats
Sasaki, T., Ito, D., Sonoda, T., Morita, Y., Wakabayashi, Y., Yamamura, T., Okamura, H., Oishi, S., Noguchi, T., Fujii, N., et al. (2019) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2018.12.011 · Cited by 20
Dynorphin A (1–8) Analog, E-2078, Is Stable in Human and Rhesus Monkey Blood
Yu, J. T., Butelman, E. R., Woods, J. H., Chait, B. T., & Kreek, M. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36529-2 · Cited by 20
Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.
Shukla, V. K., & Lemaire, S. (1992) · PubMed Central · Cited by 20
Inhibitory effects of opioids in a circular muscle-myenteric plexus preparation of guinea-pig ileum
Johnson, S. M., Costa, M., Humphreys, C. M. S., & Shearman, R. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00164876 · Cited by 20
“Both mu and kappa opioid agonists act on receptors located on neurons within the myenteric plexus, depress the firing ofmyenteric neurons (Karras and North 1981), inhibit the release of acetylcholine (Paton 1957; Schaumann 1957; Szerb 1982; Vizi et al. 1984) and reduce the nerve-mediated cholinergic contractions of th…”
BackgroundInfluential
Possible modulatory role of dynorphin on the excitation by neurotensin on the guinea pig myenteric plexus
Huidobro-Toro, J. P., & Way, E. L. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90418-9 · Cited by 20
Changes in Hypothalamic Hypophysiotropic Hormones and Neurotransmitters during Aging
Simpkins, J. W. (1983) · Springer eBooks · doi:10.1007/978-1-4684-4523-7_4 · Cited by 20
Metabolic profiling of opioid peptides in canine pituitary and selected brain regions using HPLC with a radioreceptor assay detector
Takeshita, H., Desiderio, D. M., & Fridland, G. (1986) · Biomedical Chromatography · doi:10.1002/bmc.1130010308 · Cited by 20
Cyclic Endomorphin Analogs in Targeting Opioid Receptors to Achieve Pain Relief
Janecka, A. E., & Gentilucci, L. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.132 · Cited by 19
Structure and dynamics of dynorphin peptide and its receptor
Ferré, G., Czaplicki, G., Demange, P., & Milon, A. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.05.006 · Cited by 19
“The ability to produce dynorphin and analogues by solid-phase peptide synthesis (Goldstein, et al., 1979) opened the way to a wide range of structure-activity relationship studies on various peptide structures.”
Background
Opioidvermittelte Analgesie und Hyperalgesie
Koppert, W. (2005) · Der Schmerz · doi:10.1007/s00482-005-0424-9 · Cited by 18
Differential effects of α-, β- and γ-endorphins on dopamine metabolism in the mouse brain
Kameyama, T., Ukai, M., Noma, S., & Hiramatsu, M. (1982) · Brain Research · doi:10.1016/0006-8993(82)90089-0 · Cited by 19
Opioid and Antiopioid Peptides: A Model of Yin-Yang Balance in Acupuncture Mechanisms of Pain Modulation
Han, J.-S. (2001) · Springer eBooks · doi:10.1007/978-3-642-56732-2_3 · Cited by 19
Peripheral electric stimulation attenuates the expression of cocaine-induced place preference in rats
Ren, Y.-H., Wang, B., Luo, F., Cui, C., Zheng, J.-W., & Han, J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03614-4 · Cited by 19
Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development
Szeto, H. H. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00407-7 · Cited by 19
Human Pharmacology of the Opioid Neuropeptide Dynorphin A(1–13)
Greenwald, M. K., Stitzer, M. L., & Haberny, K. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36704-7 · Cited by 19
“An abbreviated peptide, dynorphin A(1–13), was synthesized and determined to be equally potent as the natural substance in vitro (Goldstein et al., 1979).”
Sodium chloride imbibition decreases levels of immunoreactive dynorphin in the neurointermediate pituitary of rats
Hölt, V., Haarmann, I., Seizinger, B. R., & Herz, A. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90332-5 · Cited by 19
The interaction of N alpha-alkylenkephalins with opiate receptors. Tissue-dependent shifts in the opiate activity of methionine-enkephalin following N alpha-alkylation.
Summers, M. C., & Hayes, R. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69350-6 · Cited by 19
High Performance Liquid Chromatography and Proteolytic Enzyme Characterization of Peptides in Tooth Pulp Extracts
May, H. E., Tanzer, F. S., Fridland, G., Wakelyn, C., & Desiderio, D. M. (1982) · Journal of Liquid Chromatography · doi:10.1080/01483918208067623 · Cited by 19
P art IX. O piate R eceptors and the B ehavioral I mplications of E ndorphins : OPIATE RECEPTORS AND OPIOID PEPTIDES: AN OVERVIEW
Simon, E. J. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39504.x · Cited by 19
HPLC receptorassay of opioid peptides in the cerebrospinal fluid of lower back pain patients
Desiderio, D. M., Ōnishi, H., Fridland, G., Wood, G. W., & Pagidipati, D. (1987) · Biomedical Chromatography · doi:10.1002/bmc.1130020202 · Cited by 19
Kappa opioid agonists in the treatment of itch: just scratching the surface?
Beck, T. C., Wilson, E. M., Wilkes, E., Lee, L. W., Norris, R. A., & Valdebran, M. (2023) · Itch · doi:10.1097/itx.0000000000000072 · Cited by 18
“The KOR system, and its endogenous agonist ligands, the dynorphins, have wide-spread distribution and activity in the central and peripheral nervous system [45 – 49] .”
Background
Dynorphin a Analogs for the Treatment of Chronic Neuropathic Pain
Hall, S. M., Lee, Y. S., & Hruby, V. J. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.164 · Cited by 18
Relationships between Endocrine Functions and Substance Abuse Syndromes
Kreek, M. J., Borg, L., Zhou, Y., & Schluger, J. H. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50108-6 · Cited by 18
Synthesis and opioid activity of 2–substituted dynorphin A‐(1‐13) amide analogues1
Story, S., Murray, T. F., DeLander, G. E., & Aldrich, J. V. (1992) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1992.tb01454.x · Cited by 18
Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats
Hong, O., Young, G. A., & Khazan, N. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90095-0 · Cited by 18
Distribution and Localization of Regulatory Peptides
Ballesta, J., Bloom, S. R., Polak, J. M., & Batsakis, J. G. (1985) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368509165843 · Cited by 18
Mutual Antagonism of κ‐Opiate and α2‐Adrenoceptor Agonist Effects on Intrasynaptosomal Free [Ca2+]i
Adamson, P., McWilliam, J. R., Brammer, M. J., & Campbell, I. C. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13230.x · Cited by 18
Competitive binding of dynorphin-(1-13) and beta-endorphin to cerebroside sulfate in solution.
Wu, C. S., Lee, N. M., Loh, H. H., & Yang, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35702-2 · Cited by 18
α‐N‐Acetyl β‐Endorphins in the Pituitary: Immunohistochemical Localization Using Antibodies Raised Against Dynorphin(1‐13)
Weber, E., Truscott, R. J. W., Evans, C. J., Sullivan, S., Angwin, P., & Barchas, J. D. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb10823.x · Cited by 18
“cently been isolated and partially sequenced (Goldstein et al., 1979).”
Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue
Petrocelli, G., Pampanella, L., Abruzzo, P. M., Ventura, C., Canaider, S., & Facchin, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073819 · Cited by 18
“Afterwards, many other endogenous opioid ligands were identified, including dynorphin and beta-endorphin [5,6].”
Background
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development
Aldrich, J. V., & McLaughlin, J. P. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_519 · Cited by 17
Antisense mapping KOR-1: evidence for multiple kappa analgesic mechanisms
Pasternak, K. R., Rossi, G. C., Zuckerman, A., & Pasternak, G. W. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01294-9 · Cited by 17
Stabilized dynorphin derivatives for modulating antinociceptive activity in morphine tolerant rats: Effect of different routes of administration
Brúgós, B. C., Arya, V., & Hochhaus, G. (2004) · The AAPS Journal · doi:10.1208/aapsj060436 · Cited by 17
“AUC estimates obtained for N-MT Dyn A MET = AUMCtot/AUCtot (2) [(T1-T0)/(T2-T0)] × 100 ( 1 ) Figure 1. Time course of changes in MPE % after intravenous administration of 5 µmol/kg [N-Met-Tyr 1 ]-Dynorphin A(1–13) (n = 4, ), [N-Met-Tyr 1 ]-Dynorphin A(1–13) amide (n = 8, ), or saline (n = 4, ). Each value represents t…”
Antinociception Produced by 2 and 5 kHz Peripheral Stimulation in the Rat
Lin, J., Chen, X.-H., & Han, J. (1992) · International Journal of Neuroscience · doi:10.3109/00207459209000531 · Cited by 17
Lower CSF level of dynorphin(1–8) immunoreactivity in schizophrenic patients
Zhang, A. Z., Zhou, G. Z., Xi, G.-F., Gu, N. F., Xia, Z. Y., Yao, J., Chang, J. K., Webber, R., & Potkin, S. G. (1985) · Neuropeptides · doi:10.1016/0143-4179(85)90077-0 · Cited by 17
Subunit Structure and Purification of Opioid Receptors
Simon, E. J. (1987) · Journal of Receptor Research · doi:10.3109/10799898709054982 · Cited by 17
Gi proteins and calcium in dynorphin-induced hypothermia and behaviour
Cavicchini, E., Spampinato, S. M., & Ferri, S. S. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90321-v · Cited by 17
Analgesic Peptides: From Natural Diversity to Rational Design
Gach, K., Biernat, M., Kuczer, M., Adamska‐Bartłomiejczyk, A., & Kluczyk, A. (2024) · Molecules · doi:10.3390/molecules29071544 · Cited by 17
“In the 1970s, DOR-selective enkephalins [12], KOR-selective dynorphins [13,14], and non-selective β -endorphins [15] were isolated from the mammalian brain.”
Background
Membrane Interaction of Disease-Related Dynorphin A Variants
Björnerås, J., Gräslund, A., & Mäler, L. (2013) · Biochemistry · doi:10.1021/bi4004205 · Cited by 16
Supraspinal anti-allodynic and rewarding effects of endomorphins in rats
Huang, E. Y., Chen, C.-M., & Tao, P. (2004) · Peptides · doi:10.1016/j.peptides.2004.02.009 · Cited by 16
Use of 1,1,1,3,3,3-hexafluoro-2-propyl protecting group in the synthesis of dna fragments via phosphoramidite intermediates
Takaku, H., Watanabe, T., & Hamamoto, S. (1988) · Tetrahedron Letters · doi:10.1016/0040-4039(88)80022-4 · Cited by 16
In vitro Characterization of Novel Peptide Inhibitors of Endomorphin‐degrading Enzymes in the Rat Brain
Fichna, J., Janecka, A. E., Bailly, L., Marsais, F., Costentin, J., & do-Rego, J.-C. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00425.x · Cited by 16
“Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (Tyr-ProPhe-Phe-NH2), endogenous ligands of the l-opioid receptors (1), were identified about 25 years later than other opioid peptides, such as d-selective enkephalins and j-selective dynorphins (2,3).”
Background
The rise and fall of endogenous opioid nomenclature
Kitchen, I. (1984) · Progress in Neurobiology · doi:10.1016/0301-0082(84)90005-4 · Cited by 16
Pharmacokinetics of intravenous dynorphin A(1–13) in opioid-naive and opioid-treated human volunteers*
Gambús, P. L., Schnider, T. W., Minto, C. F., Youngs, E. J., Billard, V., Brose, W. G., Hochhaus, G., & Shafer, S. L. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90019-4 · Cited by 16
[3H]Leu-enkephalin binding following chronic swim-stress in mice
Christie, M. J., & CHESHER, G. B. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90020-4 · Cited by 16
Neuropeptides and Their Role in Nociception and Analgesia
Recht, L. D., & Abrams, G. (1986) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30950-2 · Cited by 16
Measurement of Total Opioid Peptides in Rat Brain and Pituitary by Radioimmunoassay Directed at the α‐N‐Acetyl Derivative
Boarder, M. R., Weber, E., Evans, C. J., Erdelyi, E., & Barchas, J. D. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb08120.x · Cited by 16
Subcellular Distribution of Opioid Peptides in Rat Hypothalamus and Pituitary
Molineaux, C. J., Rosenberger, J. G., & Cox, B. M. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06086.x · Cited by 16
Neurobiology of β-Endorphin and Related Peptides
Holaday, J. W., & Loh, H. H. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-447210-5.50012-4 · Cited by 16
A Genetic Polymorphism of the Endogenous Opioid Dynorphin Modulates Monetary Reward Anticipation in the Corticostriatal Loop
Votinov, M., Pripfl, J., Windischberger, C., Kalcher, K., Zimprich, A. A., Zimprich, F., Moser, E., Lamm, C., & Sailer, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089954 · Cited by 15
“Dynorphins bind with highest affinity to kappa opioid receptors (KOP-R), but also to mu and delta opioid receptors [5,6,7].”
Background
Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples
Muratspahić, E., White, A. M., Ciotu, C. I., Hochrainer, N., Tomašević, N., Koehbach, J., Lewis, R. J., Spetea, M., Fischer, M. J. M., Craik, D. J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00426 · Cited by 15
AGH is a new hemoglobin alpha-chain fragment with antinociceptive activity
Ribeiro, N., Toniolo, E. F., de Castro, L. M., Russo, L. C., Rioli, V., Ferro, E. S., & Dale, C. S. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.011 · Cited by 15
Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats
Chen, J., Tao, P., Li, J. Y., Wong, C.-H., & Huang, E. Y.-K. (2003) · Peptides · doi:10.1016/s0196-9781(03)00078-0 · Cited by 15
Skin peptides from anurans of the Litoria rubella Group: sequence determination using electrospray mass spectrometry. Opioid activity of two major peptides
Jackway, R. J., Maselli, V. M., Musgrave, I., Maclean, M. J., Tyler, M. J., & Bowie, J. H. (2009) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3988 · Cited by 15
Structure-NCS activity studies with the enkephalins
Coy, D. H., & Kastin, A. J. (1980) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(80)90032-7 · Cited by 15
Penetration of phospholipid monolayers by opioid peptides and opiate drugs (agonists and antagonists)
Bourhim, N., Kebbaj, M. S. E., Gargouri, Y., Giraud, P., RIETSCHOTEN, J. V., Oliver, C., & Verger, R. (1993) · Colloids and Surfaces B Biointerfaces · doi:10.1016/0927-7765(93)80020-y · Cited by 15
Clinical Update of Opioid Agonist and Partial Agonist Medications for the Maintenance Treatment of Opioid Addiction
Kreek, M. J. (1997) · Seminars in Neuroscience · doi:10.1006/smns.1997.0114 · Cited by 15
The next frontier in the molecular biology of the opioid system
Civelli, O., Machida, C. A., Bunzow, J. R., Albert, P. R., Hanneman, E. H., Salon, J. A., Bidlack, J. M., & Grandy, D. K. (1987) · Molecular Neurobiology · doi:10.1007/bf02935742 · Cited by 15
Central Neurotransmitters and Acupuncture Analgesia
Han, J. (1989) · Springer eBooks · doi:10.1007/978-3-642-73757-2_2 · Cited by 15
Dynorphin-(1–13)-Like Immunoreactivity in Central Nervous System and Pituitary Gland of Spontaneously Hypertensive Rats
Kouchich, F. J., Quock, R. M., & Tseng, L. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409044031 · Cited by 15
‘Dynorphin’ in plasma: enzymatic artifact and authentic immunoreactivity
Howlett, T. A., Walker, J. D., BESSER, G. M., & REES, L. H. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90168-x · Cited by 15
Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
Schmidhammer, H., Erli, F., Guerrieri, E., & Spetea, M. (2020) · Molecules · doi:10.3390/molecules25215092 · Cited by 14
“The endogenous kappa opioid system comprises the KOR and endogenous peptide ligands, the dynorphins, named after the Greek word dynamis (power) [18].”
Background
The effect of U-50,488H, A κ-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat
Bhargava, H. N., Matwyshyn, G. A., & Ramarao, P. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90002-n · Cited by 14
Characterization of Cysteine Proteases Functioning in Degradation of Dynorphin in Neuroblastoma Cells: Evidence for the Presence of a Novel Enzyme with Strict Specificity Toward Paired Basic Residues
Satoh, M., Yokosawa, H., & Ishii, S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10898.x · Cited by 14
Changes in the immunoreactivities of an opioid peptide leumorphin in the hypothalamus and anterior pituitary during the estrous cycle of the rat and their relation to sexual behavior
Suda, M., Nakao, K., Sakamoto, M., Morii, N., Sugawara, A., & Imura, H. (1986) · Brain Research · doi:10.1016/0006-8993(86)90417-8 · Cited by 14
Fraction I Endorphin in Cerebrospinal Fluid Clinical Studies
von Knorring, L., Terenius, L. Y., & Wahlström, A. (1983) · Springer eBooks · doi:10.1007/978-1-4615-9269-3_6 · Cited by 14
The opioid receptor: emergence through millennia of pharmaceutical sciences
Fairbanks, C. A., & Peterson, C. D. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.960389 · Cited by 13
A review of the kappa opioid receptor system in opioid use
Çayır, S., Zhornitsky, S., Barzegary, A., Carreño, E. S., Sarfo-Ansah, W., Funaro, M. C., Matuskey, D., & Angarita, G. A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105713 · Cited by 15
“In addition, although dynorphin is considered the naturally occurring ligand for the KOR (Goldstein et al., 1979), it is not highly selective and has MOR agonist activity (James and Goldstein, 1984; Zhou et al., 2015).”
Background
Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Borsodi, A. D., Bruchas, M. R., Calò, G., Chavkin, C., Christie, M. J., Civelli, O., Connor, M. A., Cox, B. M., Devi, L. A., Evans, C. J., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f50/2019.4 · Cited by 13
Biochemical and Genetic Studies of Tourette’s Syndrome
Chappell, P. B., Leckman, J. F., Pauls, D. L., & Cohen, D. J. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0525-5_15 · Cited by 13
β-Endorphin: Synthetic Analogs and Structure-Activity Relationships
Li, C. H. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-447210-5.50007-0 · Cited by 13
Regional interactions of opioid peptides at μ and δ sites in rat brain
Hewlett, W. A., & Barchas, J. D. (1983) · Peptides · doi:10.1016/0196-9781(83)90080-3 · Cited by 13

Authors: Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L.
Affiliations: California Institute of Technology (US)
ORCID: Hunkapiller, M
Hood, L
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1979-12
Volume: 76
Issue: 12
Pages: 6666-6670
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.76.12.6666
PMC: PMC411929
OpenAlex: W2033680879
Cited by: 882
References: 18
Citations by year: 2026: 8 · 2025: 9 · 2024: 8 · 2023: 14 · 2022: 10 · 2021: 14 · 2020: 23 · 2019: 13 · 2018: 8 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 16 · 2013: 23 · 2012: 18
FWCI: 24.93
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
CaltechAUTHORS (California Institute of Technology) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords: dynorphin A(1-13), opioid peptides, leu-enkephalin, enkephalin, naloxone, opioid receptors, vas deferens, peptide degradation, immunoreactivity
MeSH terms: Amino Acid Sequence, Animals, Biological Assay, Dose-Response Relationship, Drug, Endorphins, Guinea Pigs, Ileum, Radioligand Assay, Receptors, Opioid, Structure-Activity Relationship, Swine, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks